Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
A Mississippi Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that outlines the terms and conditions under which Gentling, Inc. can access and utilize certain intellectual property developed or owned by The University of North Texas Health Science Center in the state of Mississippi. This agreement grants Gentling, Inc. a license to use the intellectual property for specific purposes, such as research, development, manufacturing, and commercialization of products or services, subject to the conditions and limitations set forth in the agreement. The Mississippi Collateral License Agreement may cover a variety of intellectual property assets, including but not limited to patents, copyrights, trade secrets, trademarks, and know-how. The specific types of intellectual property licensed under the agreement will be clearly defined and listed in the agreement itself. The agreement will outline the rights and obligations of both parties, including the scope of the license, any exclusivity granted, any restrictions on the use or transfer of the intellectual property, and any financial considerations, such as royalties or upfront fees that Gentling, Inc. may need to pay to The University of North Texas Health Science Center in exchange for the license. Different types of Mississippi Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may include: 1. Patent Collateral License Agreement: This grants Gentling, Inc. the right to utilize and commercialize specific patented technologies or inventions owned or developed by The University of North Texas Health Science Center in Mississippi. 2. Copyright Collateral License Agreement: This allows Gentling, Inc. to use copyrighted content, such as software, publications, or educational materials, owned by The University of North Texas Health Science Center, for specified purposes. 3. Trade Secret Collateral License Agreement: This agreement provides Gentling, Inc. with access to valuable trade secrets or proprietary information of The University of North Texas Health Science Center, which may be crucial for the development and success of certain products or technologies. 4. Trademark Collateral License Agreement: This permits Gentling, Inc. to use and/or sublicense specific trademarks owned by The University of North Texas Health Science Center, enabling them to market and promote products or services under those trademarks in Mississippi. Overall, the Mississippi Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center establishes a mutually beneficial relationship between the two entities, allowing for the lawful and regulated utilization of intellectual property for the advancement of scientific research and commercial ventures.
A Mississippi Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that outlines the terms and conditions under which Gentling, Inc. can access and utilize certain intellectual property developed or owned by The University of North Texas Health Science Center in the state of Mississippi. This agreement grants Gentling, Inc. a license to use the intellectual property for specific purposes, such as research, development, manufacturing, and commercialization of products or services, subject to the conditions and limitations set forth in the agreement. The Mississippi Collateral License Agreement may cover a variety of intellectual property assets, including but not limited to patents, copyrights, trade secrets, trademarks, and know-how. The specific types of intellectual property licensed under the agreement will be clearly defined and listed in the agreement itself. The agreement will outline the rights and obligations of both parties, including the scope of the license, any exclusivity granted, any restrictions on the use or transfer of the intellectual property, and any financial considerations, such as royalties or upfront fees that Gentling, Inc. may need to pay to The University of North Texas Health Science Center in exchange for the license. Different types of Mississippi Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may include: 1. Patent Collateral License Agreement: This grants Gentling, Inc. the right to utilize and commercialize specific patented technologies or inventions owned or developed by The University of North Texas Health Science Center in Mississippi. 2. Copyright Collateral License Agreement: This allows Gentling, Inc. to use copyrighted content, such as software, publications, or educational materials, owned by The University of North Texas Health Science Center, for specified purposes. 3. Trade Secret Collateral License Agreement: This agreement provides Gentling, Inc. with access to valuable trade secrets or proprietary information of The University of North Texas Health Science Center, which may be crucial for the development and success of certain products or technologies. 4. Trademark Collateral License Agreement: This permits Gentling, Inc. to use and/or sublicense specific trademarks owned by The University of North Texas Health Science Center, enabling them to market and promote products or services under those trademarks in Mississippi. Overall, the Mississippi Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center establishes a mutually beneficial relationship between the two entities, allowing for the lawful and regulated utilization of intellectual property for the advancement of scientific research and commercial ventures.